Regenerative Medical Technology (RMTG) EV to FCF (2018 - 2026)

Regenerative Medical Technology has reported EV to FCF for 9 years, with the latest figure at 2.21 in Q2 2026.

• On a quarterly basis, EV to FCF fell 218.57% year-over-year to 2.21 in Q2 2026; TTM through Jun 2026 was 1.09, a 100.76% increase from a year earlier, with the FY2025 full-year figure at 0.23, up 118.42% from the prior year.
• EV to FCF was 2.21 for Q2 2026 at Regenerative Medical Technology, down from 3.13 in the prior quarter.
• The five-year high for EV to FCF was 12.35 in Q3 2023, with the low at 1076.61 in Q1 2023.
• Average EV to FCF over 5 years is 58.7, with a median of 1.3 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EV to FCF surged 23013.7% in 2022, then sank 34622.96% in 2023.
• Over 5 years, EV to FCF stood at 7.45 in 2022, then slumped by 82.63% to 1.29 in 2023, then plunged by 285.23% to 2.4 in 2024, then jumped by 154.61% to 1.31 in 2025, then tumbled by 268.5% to 2.21 in 2026.
• The last three EV to FCF figures came in at 2.21 (Q2 2026), 3.13 (Q1 2026), and 1.31 (Q4 2025), per Business Quant data.